Identification of novel genetic variations affecting osteoarthritis patients

BMC Med Genet. 2016 Oct 10;17(Suppl 1):68. doi: 10.1186/s12881-016-0330-2.

Abstract

Background: Osteoarthritis (OA) is a progressive joint disease characterized by gradual degradation of extracellular matrix (ECM) components in the cartilage and bone. The ECM of cartilage is a highly specified structure that is mainly composed of type II collagen and provides tensile strength to the tissue via aggrecan and proteoglycans. However, changes in the ECM composition and structure can lead to loss of collagen type II and network integrity. Several risk factors have been correlated with OA including age, genetic predisposition, hereditary factors, obesity, mechanical injuries, and joint trauma. Certain genetic association studies have identified several genes associated with OA using genome-wide association studies (GWASs).

Results: We identified several novel genetic variants affecting genes that function in several candidate causative pathways including immune responses, inflammatory and cartilage degradation such as SELP, SPN, and COL6A6.

Conclusions: The approach of whole-exome sequencing can be a promising method to identify genetic mutations that can influence the OA disease.

Keywords: Osteoarthritis; Single nucleotide variants; Whole-exome sequencing.

MeSH terms

  • Aged
  • Cartilage / metabolism
  • Collagen Type II / genetics
  • Collagen Type VI / genetics
  • Exome / genetics*
  • Genetic Variation*
  • Genome-Wide Association Study
  • Humans
  • Leukosialin / genetics
  • Middle Aged
  • Osteoarthritis / genetics*
  • Osteoarthritis / pathology
  • P-Selectin / genetics
  • Polymorphism, Single Nucleotide
  • Risk Factors

Substances

  • COL2A1 protein, human
  • COL6A6 protein, human
  • Collagen Type II
  • Collagen Type VI
  • Leukosialin
  • P-Selectin
  • SELP protein, human
  • SPN protein, human